← Back to Bills
H.R. 4975House113th Congress (2013-2015)In Committee

SALTS Act

Sponsored by Mac ThornberryRep. Mac Thornberry (R-TX)
Introduced June 25, 2014

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
HouseCommittee Latest Action

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Crime and Federal Government Surveillance Subcommittee

July 21, 2014

View full timeline
HouseIntro Referral

Introduced in House

June 25, 2014

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Energy and Commerce Committee

June 25, 2014

HouseCommittee

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Crime and Federal Government Surveillance Subcommittee

July 21, 2014

Bill Text

Latest available legislative text

Reading Mode
Latest
Raw Text PDF XML
Introduced in HouseIssued June 25, 2014

I

113th CONGRESS

2d Session

H. R. 4975

IN THE HOUSE OF REPRESENTATIVES

June 25, 2014

Mr. Thornberry (for himself and Mr. Smith of Texas) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Controlled Substances Act relating to controlled substance analogues.

1.

Short title

This Act may be cited as the Synthetic Abuse and Labeling of Toxic Substances Act of 2014 or the SALTS Act.

2.

Controlled substance analogues

Section 203 of the Controlled Substances Act (21 U.S.C. 813) is amended—

(1)

by striking A controlled and inserting (a) In general.—A controlled; and

(2)

by adding at the end the following:

(b)

Determination

In determining whether a controlled substance analogue was intended for human consumption under subsection (a), the following factors may be considered, along with any other relevant factors:

(1)

The marketing, advertising, and labeling of the substance.

(2)

The known efficacy or usefulness of the substance for the marketed, advertised or labeled purpose.

(3)

The difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold.

(4)

The diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance.

(5)

Whether the defendant knew or should have known the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.

(c)

Limitation

For purposes of this section, evidence that a substance was not marketed, advertised, or labeled for human consumption, by itself, shall not be sufficient to establish that the substance was not intended for human consumption.

.